Search

Search Constraints

You searched for: Author/Creator Mei, Matthew

Search Results

1. Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia. Issue 10 (10th July 2019)

2. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure. Issue 12 (12th April 2018)

3. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial. Issue 1 (January 2023)

6. Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma. (21st April 2020)

7. Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. Issue 10 (12th February 2020)

8. Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. Issue 5 (18th February 2021)

9. Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy. Issue 14 (5th December 2020)

10. Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia. Issue 10 (28th July 2020)